Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weill-Marchesani Syndrome | 1 | 2013 | 1 | 0.440 |
Why?
|
| Limb Deformities, Congenital | 1 | 2013 | 12 | 0.440 |
Why?
|
| Bone Diseases, Developmental | 1 | 2013 | 16 | 0.430 |
Why?
|
| Mutation, Missense | 3 | 2019 | 315 | 0.400 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1416 | 0.340 |
Why?
|
| Genetic Association Studies | 3 | 2023 | 361 | 0.310 |
Why?
|
| Neurofibromin 1 | 2 | 2019 | 26 | 0.310 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2023 | 155 | 0.300 |
Why?
|
| Neurofibromatosis 1 | 2 | 2019 | 45 | 0.300 |
Why?
|
| Epilepsy | 2 | 2023 | 322 | 0.270 |
Why?
|
| Intellectual Disability | 2 | 2023 | 151 | 0.220 |
Why?
|
| Whole Genome Sequencing | 2 | 2021 | 130 | 0.210 |
Why?
|
| Language Disorders | 1 | 2018 | 33 | 0.150 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 25 | 0.150 |
Why?
|
| Speech Disorders | 1 | 2018 | 34 | 0.150 |
Why?
|
| Megalencephaly | 1 | 2018 | 19 | 0.150 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2018 | 11 | 0.150 |
Why?
|
| Acyltransferases | 1 | 2018 | 53 | 0.150 |
Why?
|
| Homozygote | 1 | 2018 | 192 | 0.140 |
Why?
|
| Codon | 1 | 2017 | 86 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2021 | 384 | 0.140 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 97 | 0.140 |
Why?
|
| Protein Domains | 1 | 2018 | 252 | 0.140 |
Why?
|
| DNA Helicases | 1 | 2018 | 149 | 0.140 |
Why?
|
| Alleles | 1 | 2019 | 844 | 0.130 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 257 | 0.120 |
Why?
|
| Critical Illness | 1 | 2021 | 730 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2018 | 1142 | 0.110 |
Why?
|
| Fibrillin-1 | 1 | 2013 | 3 | 0.110 |
Why?
|
| ADAMTS Proteins | 1 | 2013 | 5 | 0.110 |
Why?
|
| Fibrillins | 1 | 2013 | 7 | 0.110 |
Why?
|
| Dwarfism | 1 | 2013 | 15 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2013 | 58 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2013 | 25 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2018 | 933 | 0.100 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 125 | 0.100 |
Why?
|
| Point Mutation | 1 | 2013 | 223 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 178 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1105 | 0.100 |
Why?
|
| Phenotype | 4 | 2023 | 3044 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2264 | 0.090 |
Why?
|
| Heterozygote | 2 | 2019 | 267 | 0.070 |
Why?
|
| GTP Phosphohydrolases | 1 | 2023 | 84 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 155 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 313 | 0.040 |
Why?
|
| California | 1 | 2021 | 398 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 5388 | 0.040 |
Why?
|
| Female | 5 | 2021 | 68154 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 277 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 281 | 0.040 |
Why?
|
| Humans | 7 | 2023 | 128418 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 161 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 101 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2021 | 505 | 0.040 |
Why?
|
| Demography | 1 | 2017 | 277 | 0.030 |
Why?
|
| Medicaid | 1 | 2021 | 433 | 0.030 |
Why?
|
| Critical Care | 1 | 2021 | 541 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 683 | 0.030 |
Why?
|
| Infant | 2 | 2021 | 8914 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 2040 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1480 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 1828 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1456 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2017 | 939 | 0.030 |
Why?
|
| Adult | 1 | 2013 | 35300 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 5687 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 7036 | 0.020 |
Why?
|
| Male | 3 | 2021 | 62858 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 5039 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 10152 | 0.020 |
Why?
|
| United States | 1 | 2021 | 13830 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 10384 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 12312 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 20179 | 0.010 |
Why?
|
| Child | 1 | 2017 | 20655 | 0.010 |
Why?
|